Vishal Ratanpaul
Glucagon-like peptide-1 (GLP-1) receptor agonists have produced the largest pharmacological reductions in body weight yet achieved. Their success is most usefully read not as a new target but as validation of an endogenous physiology the gut already possesses - the satiety and gastric-emptying actions of endogenous GLP-1 described decades ago - and of appetite regulation as a tractable target. Yet food engages this physiology weakly and inconsistently. This Perspective argues that satiety is not a single signal but a spatially and temporally distributed cascade - oro-sensory at the mouth, volumetric at the stomach, nutrient chemosensing at the duodenum, direct enteroendocrine sensing at the ileum, and fermentative signalling in the colon - and that food matrix structure is the common variable governing engagement at each station. Food processing acts on this architecture: a softened matrix shortens oral exposure and speeds gastric emptying, while raised digestibility diverts substrate from the distal small intestine and colon. Recent human work shows that a single structural lever - intact plant cells that carry starch past proximal digestion - can raise endogenous GLP-1 and PYY. This is read here not as a solution but as proof of principle for a larger, largely unattempted programme: designing multi-component matrices that engage several stations rather than one. Treating structural digestibility as a measurable variable, the analysis draws on in vivo evidence linking matrix architecture to ileal escape, transit, colonic fermentation and intake, while making explicit where that evidence is strong and where - particularly for colonic signalling in humans - it remains unproven. It sets out what must be established for multi-site, food-based appetite engineering to become testable and, ultimately, clinically useful.